A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health

Abroad (travel likely)Recruiting

Conditions

Obesity and Overweight

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Able Biolabs, LLC, Birmingham, Alabama, United States
Contact: Study coordinator (Moroni Berrios) · moroni@ablebiolabs.com · 3612496084

Study leads

Ahmed Abdelgawad, MD
Principal Investigator
Able Biolabs, LLC

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Obesity · Overweight · Diabetes Mellitus, Type 2

Abroad (travel likely)RecruitingPHASE2

Gilbert, United States · Phoenix, United States

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Atherosclerotic Cardiovascular Disease · Overweight · Obesity

Abroad (travel likely)RecruitingPHASE3

Daphne, United States · Fairhope, United States

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Obesity · Overweight · Obstructive Sleep Apnoea

Abroad (travel likely)RecruitingPHASE3

Gilbert, United States · Bradenton, United States

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.

Healthy Participants · Obesity

Abroad (travel likely)RecruitingPHASE1

Glendale, United States · Brooklyn, United States